NCT06165601View on ClinicalTrials.gov

Proteinuria in Renal Transplant Patients Treated with Dapagliflozin

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 4, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

January 1, 2026

Conditions
Chronic Kidney Diseases
Interventions
PROCEDURE

Follow-up at D14

A blood test and urinary test will be performed at D14.

PROCEDURE

Follow-up at M1

A blood test and urinary test will be performed at M1.

Trial Locations (1)

34295

RECRUITING

University Hospital of Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER